2018 Volume 35 Issue 4 Pages 439-443
Stroke is a disease with a high risk of recurrence. Annual recurrence rate of stroke is 5% on average for 10 years, and this rate is higher immediately after stroke and in the case of cardioembolism. Recent advance of stroke prevention strategy includes introduction of novel drugs such as PCSK9 inhibitor and direct oral anticoagulants (DOAC), and revision of standards for antithrombotic therapy during peri–surgical period or in the presence of cryptogenic stroke or multiple cerebral microbleeds. This review overviews therapeutic strategy for stroke, focusing especially on the recent advancement.
